SUCNR1 and neoplasm: This hypothesis outlines future research steps: measuring succinate in tumor tissues for correlation with serum levels, verifying HIF-1α and SUCNR1 activity in patient samples or in vitro, and designing experiments using SUCNR1 antagonists or HIF-1α inhibitors to determine the importance of these pathways for JFAD’s efficacy.